Development Of Syzygium Cumini Seed Tablets And Their Pharmaceutical Evaluation

Diabetes mellitus is a major global health concern requiring safer and cost-effective therapeutic options. Syzygium cumini (Jamun) seeds are traditionally used for their antidiabetic properties due to the presence of bioactive compounds such as flavonoids and alkaloids. This study focuses on the formulation and evaluation of Jamun seed powder tablets as a potential antidiabetic agent. The seed powder was processed and compressed into tablets using suitable excipients, followed by evaluation of physicochemical parameters including hardness, friability, weight variation, and disintegration time. The antidiabetic activity was assessed using in vitro enzyme inhibition assays. The findings are expected to support the effectiveness of Jamun seed tablets as a natural and economical alternative for diabetes management.